Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FSCN1 | Q16658 | 1/20 | 0.54 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.47 |
| ▸ | F2R | P25116 | 1/20 | 0.42 |
| ▸ | KCNK3 | O14649 | 4/20 | 0.41 |
| ▸ | KCNK9 | Q9NPC2 | 4/20 | 0.41 |
| ▸ | CPT1A | P50416 | 1/20 | 0.40 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PNLIP | P16233 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17038996 | 0.91 | FSCN1 (0.66) | FSCN1PTGER4F2RKCNK3KCNK9 | |
| SCHEMBL30694980 | 0.91 | FSCN1 (0.66) | FSCN1PTGER4F2RKCNK3KCNK9 | |
| SCHEMBL18937374 | 0.85 | FSCN1 (0.59) | FSCN1PTGER4F2RRXFP1MAPT | |
| SCHEMBL17199332 | 0.83 | FSCN1 (0.54) | FSCN1PTGER4CPT1ACPT1BCNR1 | |
| SCHEMBL18532151 | 0.83 | FSCN1 (0.53) | FSCN1PTGER4CPT1ACPT1BCNR1 | |
| SCHEMBL17195535 | 0.82 | FSCN1 (0.66) | FSCN1PTGER4CPT1ACPT1BSMN1; SMN2 | |
| SCHEMBL17038917 | 0.80 | FSCN1 (0.64) | FSCN1PTGER4CPT1ACPT1BCNR1 | |
| SCHEMBL30694976 | 0.80 | FSCN1 (0.64) | FSCN1PTGER4CPT1ACPT1BCNR1 | |
| SCHEMBL17199374 | 0.80 | FSCN1 (0.51) | FSCN1PTGER4CPT1ACPT1BMAPK8 | |
| SCHEMBL17199347 | 0.80 | FSCN1 (0.60) | FSCN1PTGER4CPT1ACPT1BSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170158692-A1 | COMPOUNDS AND METHODS FOR INHIBITING FASCIN | CORNELL UNIVERSITY | 2017-06-08 | — | — | US | disclosed |
| US-9573946-B2 | Compounds and methods for inhibiting fascin | NOVITA PHARMACEUTICALS, INC. (US) | 2017-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158692-A1 | COMPOUNDS AND METHODS FOR INHIBITING FASCIN | FSCN1, MTPN, MYOF | FSCN1 1/4885PTGER4 4107/4885F2R 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.